Understanding the distinct physiological and developmental considerations in pediatric pulmonology is essential for improving care in children with acute and chronic respiratory illnesses. Conditions such as bronchiolitis, cystic fibrosis, and pediatric asthma require age-specific diagnostic criteria and therapeutic strategies. Advances in pediatric ventilatory support, genetic testing for early-onset diseases, and child-adapted pulmonary rehabilitation techniques are creating new pathways for early intervention. Research into neonatal lung development and epigenetic factors contributing to respiratory conditions is gaining momentum. The field of Pediatric Pulmonology is also integrating family-centered care and telehealth innovations, ensuring continuity and quality of treatment in diverse healthcare settings. Ethical challenges in pediatric research, such as informed consent and long-term follow-up, are also being addressed through novel regulatory frameworks. As a result, pediatric lung care is evolving into a precision-guided, longitudinal approach rooted in early risk identification.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation